SEMICAL Teknoloji A.Ş. has been honored at the İnovaLİG 2025 awards ceremony, receiving a prestigious award in the “Innovation Organization and Culture” category. The event, held under the coordination of the Republic of Türkiye Ministry of Commerce and hosted by the Turkish Exporters Assembly (TİM), recognized SEMICAL as the second-place winner in Turkey for this category, marking a significant achievement for the company.
The award was presented to Prof. Dr. Serdar Sezer by the Minister of Commerce, Prof. Dr. Ömer Bolat; the Minister of Labor and Social Security, Prof. Dr. Vedat Işıkhan; and TİM President Mustafa Gültepe.
From Science to Production: An Integrated Culture of Innovation
Placing scientific research and innovation at the heart of its corporate culture, SEMICAL Teknoloji has established an integrated, production-oriented ecosystem between its R&D laboratories at Isparta Süleyman Demirel University Technopark and its modern GMP manufacturing facility in the Antalya Organized Industrial Zone.
This structure embodies the company’s “From Lab to Production” philosophy, ensuring that academic knowledge is effectively translated into industrial output. The company’s R&D activities are led by Dr. Ümran Aydemir Sezer, a faculty member at Süleyman Demirel University’s Department of Medical Pharmacology and Regenerative Medicine. The innovative solutions developed for biomaterial and regenerative medicine-based medical devices are bringing Türkiye’s scientific expertise in biotechnology to the global stage. By embracing innovation not just on a project basis but as a sustainable corporate identity, SEMICAL is defined as an exemplary enterprise guiding the transformation of our country’s health technologies.
A Model Emerging from the SDU Health Ecosystem
As one of the pioneering examples of Süleyman Demirel University’s health-focused university-industry collaboration model, SEMICAL is a vital component of the innovative health ecosystem developing in Türkiye’s “Lakes Region.” The region provides a robust research and innovation infrastructure for biotechnology-focused companies like SEMICAL, offering university facilities, clinical and preclinical research opportunities, and well-equipped laboratories capable of conducting tests and analyses compliant with pharmacopeia standards. This ecosystem serves as an exemplary model that supports the growth of university-originated industries and fosters new success stories from the region.
New Investment Aligned with the National Technology Move
In line with Türkiye’s “National Technology Move” vision, SEMICAL is making a new biotechnology investment in the field of regenerative medicine under the HAMLE Program, supported by the Ministry of Industry and Technology.
Regulatory Approvals in Nearly 40 Countries
SEMICAL has successfully completed registration and GMP certification processes in nearly 40 countries across Europe, the Middle East, Latin America, and Asia. As the company strengthens its international presence, it is poised to become a high-value-added player in Türkiye’s biotechnology exports.
Positioned to Become One of Türkiye’s Future Turcorns
Guided by the leadership of Dr. Ümran Aydemir Sezer and Prof. Dr. Serdar Sezer, SEMICAL Teknoloji continues to operate under its motto of “producing with science, growing with innovation.” With its scientific approach, robust manufacturing infrastructure, and a management model that has turned innovation into a core corporate identity, SEMICAL is positioned to become one of Türkiye’s leading biotechnology brands and a future “Turcorn” (a Turkish Unicorn).
Related
